CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 1, February 2012
50
AFRICA
Prevalence of prehypertension and associated risk factors in a rural
Taiwanese adult population.
Int J Cardiol
2009 Feb 14. [Epub ahead
of print].
26. Ling LL, Zhao JB, Zhao YJ, Fu SY, Wang FM, Yang LT, Dong LH.
Prevalence and risk factors of prehypertensive status in people from the
rural area of Lanxi county, Heilongjiang province.
Zhonghua Liu Xing
Bing Xue Za Zhi.
2008;
29
(10): 970–974.
27. Sit JW, Sijian L, Wong EM, Yanling Z, Ziping W, Jianqiang J,
et al
.
Prevalence and risk factors associated with prehypertension: identifica-
tion of foci for primary prevention of hypertension.
J Cardiovasc Nurs
2010;
25
(6): 461–469.
28. Sun Z, Zheng L, Wei Y, Li J, Zhang X, Zhang X,
et al
. Prevalence and
risk factors of the rural adult people prehypertension status in Liaoning
Province of China.
Circ J
2007;
71
(4): 550–553.
29. Tsai PS, Ke TL, Huang CJ, Tsai JC, Chen PL, Wang SY, Shyu
YK. Prevalence and determinants of prehypertension status in the
Taiwanese general population.
J Hypertens
2005;
23
(7): 1355–1360.
30. Yadav S, Boddula R, Genitta G, Bhatia V, Bansal B, Kongara S,
et al
.
Prevalence and risk factors of pre-hypertension and hypertension in
an affluent north Indian population.
Indian J Med Res
2008;
12
8(6):
712–720.
31. Yang J, Lu F, Zhang C, Liu Z, Zhao Y, Gao F,
et al
. Prevalence of
prehypertension and hypertension in a Chinese rural area from 1991 to
2007.
Hypertens Res
2010;
33
(4): 331–337.
32. Yu D, Huang J, Hu D, Chen J, Cao J, Li J, Gu D. Prevalence and
risk factors of prehypertension among Chinese adults.
J Cardiovasc
Pharmacol
2008;
52
(4): 363–368.
33. Natali A, Muscelli E, Casolaro A, Nilsson P, Melander O, Lalic N,
et
al
. Metabolic characteristics of prehypertension: role of classification
criteria and gender.
J Hypertens
2009;
27
(12): 2394–2402.
34. Van Rossum CT, van de Mheen H, Witteman JC, Hofman A,
Mackenbach JP, Grobbee DE. Prevalence, treatment, and control of
hypertension by sociodemographic factors among the Dutch elderly.
Hypertension
2000;
35
(3): 814–821.
35. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness,
treatment, control and risk factors of hypertension in Korea: the Ansan
study.
J Hypertens
2001;
19
(9): 1523–1532.
36. Midha T, Idris MZ, Saran RK, Srivastav AK, Singh SK. Prevalence
and determinants of hypertension in the urban and rural population of
a north Indian district.
East Afr J Public Health
2009;
6
(3): 268–273.
37. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ,
et
al
. Evidence based guidelines for cardiovascular disease prevention in
women: 2007 update.
Circulation
2007;
115
: 1481–1501.
38. Yanes LL, Romero DG, Iliescu R, Zhang H, Davis D, Reckelhoff JF.
Postmenopausal hypertension: role of the renin-angiotensin system.
Hypertension
2010;
56
(3): 359–363.
39. Boschitsch E, Mayerhofer S, Magometschnigg D. Hypertension in
women: the role of progesterone and aldosterone.
Climacteric
2010;
13
(4): 307–313.
40. Hart EC, Charkoudian N, Miller VM. Sex, hormones and neuroeffector
mechanisms.
Acta Physiol (Oxf)
2010 Sep 27. [Epub ahead of print].
41. Brandin LM, Gustafsson H, Ghanoum B, Milsom I, Manhem K. Effects
of estrogen plus progesterone on hemodynamic and vascular reactiv-
ity in hypertensive postmenopausal women.
Blood Press
2010;
19
(3):
156–163.
42. Olszanecka A, Po
ś
nik-Urba
ń
ska A, Kawecka-Jaszcz K, Czarnecka
D, Fedak D. Adipocytokines and blood pressure, lipids and glucose
metabolism in hypertensive perimenopausal women. Kardiol Pol 2010;
68
(7): 753–760.
43. Yamori Y, Liu L, Mu L. Diet-related factors, educational levels and
blood pressure in a Chinese population sample: findings from the
Japan-China Cooperative Research Project.
Hypertens Res
2002;
25
:
559–564.
44. Nola IA, Doko Jelini
ć
J, Bergovec M, Ruzi
ć
A, Persi
ć
V. Dietary habits
and cardiovascular diseases.
Acta Med Croatica
2010;
64
(2): 89–95.
45. Duangtep Y, Narksawat K, Chongsuwat R, Rojanavipart P. Association
between an unhealthy lifestyle and other factors with hypertension
among hill tribe populations of Mae Fah Luang District, Chiang Rai
Province, Thailand.
Southeast Asian J Trop Med Public Health
2010;
41
(3): 726–734.
46. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of
frequency of progression to hypertension in non-hypertensive partici-
pants in the Framingham Heart Study: a cohort study.
Lancet
2001;
358
: 1682–1686.
47. Mainous AG III, Everett CJ, Liszka H, King DE, Egan BM.
Prehypertension and mortality in a nationally representative cohort.
Am
J Cardiol
2004;
94
: 1496 –1500.
48. Russell LB, Valiyeva E, Carson JL. Effects of prehypertension on
admissions and deaths: a simulation.
Arch Intern Med
2004;
164
:
2119–2124.
Diary for 2012 diabetes congresses
DATE
PLACE
CONFERENCE
8–11 February Barcelona, Spain
5th International Conference on Advanced Technologies and Treatments for Diabetes
19–22 April
Bantry Bay, South Africa
SEMDSA/NOFSA 1012 Congress
5–9 May
Florence, Italy
European Congress of Endocrinology
8–12 June
Philadelphia, USA
72nd American Diabetes Association Scientific Sessions
24–26 July
Johannesburg, South Africa
CDE Centres for Diabetes and Endocrinology
10–13 October Istanbul, Turkey
ISPAD 2012 – 38th Annual Meeting of the International Society for Pediatric and
Adolescent Diabetes
4–6 December Dubai, United Arab Emirates
1st American Diabetes Association Middle East Congress ‘Diabetes Prevention and
Treatment’
